Skint, Your opinion of whether my post trashed this company is of no concern to me..and I do not intend on wasting time reposting now you replies are becoming emotional..
How you drew the false conclusion that I expected the clinical trials and development path to go perfectly smoothly is beyond my ability to understand.. Another company which I have holding 12 times bigger than PBT have had two major clinical stuff ups.. But I still have invested very heavily backing both the science and Management.. You have made unfounded statements about my expectations of clinical trials. NEU is the company and its clearly recorded here on HC that I had backed that company when nobody else wanted to know about it..so I will stand by my record in this case.
Why I won't waste time debating with you is because this subject has such a long history...as for ACL i have been following them since pre-IPO including indirect holdings/exposure through MCA..As for PBT I traded them from the first day of initial IPO... And followed them closely
since. So that is a very long history of management to debate..
Many of the best posts regarding the problems at ACL have been moderated, and whilst you don't want to look into the history thats fine.. Digging up links on the internet and posting them is all good fun...but I will stick with my experience here..and you are welcome to disagree..
the new hire, page-10
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $105.3K | 35.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 103207352 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 30327813 | 3 |
View Market Depth
| Last trade - 12.17pm 16/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |